Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
The zero based budgeting philosophy offers a fresh perspective on managing finances. Discover how it can transform your budgeting approach.
15,925 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
In volatile markets, investors seek safety. This guide compares gold, silver, bitcoin, and dividend stocks as safe ha...
A broad crypto rebound is lifting Coinbase as the company pivots toward subscriptions and services. Analysts see upsi...
AI-driven data centers are reshaping memory supply. This article breaks down what data centers will consume for memor...
A hawkish signal from a former Fed leader could shift how investors price inflation. This deep dive explains what kev...
A Windows malware strain is redirecting copied wallet addresses to attackers, prompting urgent advice to spot crypto ...
A fresh memory company touts a coiled-spring architecture to outpace NAND rivals amid AI-driven demand, sparking a co...
Could a Palantir competitor deliver the kind of upside that fans of AI software chase? This article breaks down the c...
A newly launched ETF that automates the wheel strategy is delivering about 12% yield as markets swing, offering a mec...
Markets can climb for years, but today’s warning signs hint at a tougher road ahead. This guide breaks down the histo...
ANSEM surged 299% over the past week, reviving momentum in Solana's memecoin scene and lifting overall ecosystem acti...
As AI expands, data-center construction flourishes. This piece explains why sterling infrastructure should regain mom...